DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
0.6257
-0.0110 (-1.73%)
At close: Jul 11, 2025, 4:00 PM
0.5903
-0.0354 (-5.66%)
After-hours: Jul 11, 2025, 7:10 PM EDT
DURECT Market Cap
DURECT has a market cap or net worth of $19.42 million as of July 11, 2025. Its market cap has decreased by -57.96% in one year.
Market Cap
19.42M
Enterprise Value
13.13M
1-Year Change
-57.96%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since September 28, 2000, DURECT's market cap has decreased from $660.10M to $19.42M, a decrease of -97.06%. That is a compound annual growth rate of -13.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 10, 2025 | 19.80M | -15.02% |
Dec 31, 2024 | 23.30M | 32.39% |
Dec 29, 2023 | 17.60M | -77.66% |
Dec 30, 2022 | 78.80M | -64.87% |
Dec 31, 2021 | 224.30M | -46.67% |
Dec 31, 2020 | 420.60M | -42.46% |
Dec 31, 2019 | 731.00M | 833.59% |
Dec 31, 2018 | 78.30M | -42.80% |
Dec 29, 2017 | 136.90M | -26.28% |
Dec 30, 2016 | 185.70M | -30.29% |
Dec 31, 2015 | 266.40M | 196.99% |
Dec 31, 2014 | 89.70M | -49.21% |
Dec 31, 2013 | 176.60M | 118.56% |
Dec 31, 2012 | 80.80M | -21.71% |
Dec 30, 2011 | 103.20M | -65.58% |
Dec 31, 2010 | 299.80M | 39.90% |
Dec 31, 2009 | 214.30M | -22.86% |
Dec 31, 2008 | 277.80M | -41.66% |
Dec 31, 2007 | 476.20M | 55.67% |
Dec 29, 2006 | 305.90M | 13.25% |
Dec 30, 2005 | 270.10M | 58.98% |
Dec 31, 2004 | 169.90M | 32.84% |
Dec 31, 2003 | 127.90M | 25.52% |
Dec 31, 2002 | 101.90M | -81.72% |
Dec 31, 2001 | 557.50M | -0.16% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 706.45B |
Johnson & Johnson | 376.02B |
AbbVie | 336.71B |
Novo Nordisk | 308.58B |
UnitedHealth Group | 274.78B |
Novartis AG | 240.09B |
Abbott Laboratories | 231.78B |
AstraZeneca | 218.25B |